安进(AMGN)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

AMGN 安进

已收盘 10-27 16:00:00 EDT

291.16

-0.60

-0.21%

盘后291.00

-0.16-0.05%

19:57 EDT

最高292.00	最低288.26	成交量179.46万
今开291.21	昨收291.76	日振幅1.28%
总市值1,567亿	流通市值1,564亿	总股本5.38亿
成交额5.21亿	换手率0.33%	流通股本5.37亿
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

数据加载中...

北京优虎网络科技有限公司

{"stockData":{"symbol":"AMGN","market":"US","secType":"STK","nameCN":"安进","latestPrice":291.16,"timestamp":1761595200000,"preClose":291.76,"halted":0,"volume":1794573,"hourTrading":{"tag":"盘后","latestPrice":291,"preClose":291.16,"latestTime":"19:57 EDT","volume":95749,"amount":27878242.3651,"timestamp":1761609421809},"delay":0,"floatShares":536994627,"shares":538361851,"eps":12.23,"marketStatus":"已收盘","change":-0.6,"latestTime":"10-27 16:00:00 EDT","open":291.21,"high":291.9999,"low":288.26,"amount":521018253.46989,"amplitude":0.012818,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":12.23,"tradingStatus":0,"nextMarketStatus":{"tag":"盘前交易","tradingStatus":1,"beginTime":1761638400000},"marketStatusCode":5,"adr":0,"adrRate":0,"listingDate":423288000000,"exchange":"NASDAQ","adjPreClose":291.76,"dividendRate":0.031804,"preHourTrading":{"tag":"盘前","latestPrice":291.21,"preClose":291.76,"latestTime":"09:29 EDT","volume":797,"amount":232161.7962,"timestamp":1761571799999},"postHourTrading":{"tag":"盘后","latestPrice":291,"preClose":291.16,"latestTime":"19:57 EDT","volume":95749,"amount":27878242.3651,"timestamp":1761609421809},"volumeRatio":1.162405,"impliedVol":0.3051,"impliedVolPercentile":0.612},"requestUrl":"/m/hq/s/AMGN","defaultTab":"news","newsList":[{"id":"1117083876","title":"恩多推出美国首个也是唯一的Ravicti®（甘油苯丁酸酯）口服液的仿制药","url":"https://stock-news.laohu8.com/highlight/detail?id=1117083876","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1117083876?lang=zh_cn&edition=full","pubTime":"2025-10-20 19:33","pubTimestamp":1760959996,"startTime":"0","endTime":"0","summary":"恩多推出美国首个也是唯一的Ravicti®（甘油苯丁酸酯）口服液的仿制药","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU2468319806.SGD","IE00BJT1NW94.SGD","LU2089984988.USD","LU1023059063.AUD","LU1983299246.USD","BK4566","LU0109394709.USD","BK4139","LU0289739699.SGD","LU0320765992.SGD","BK4581","IE0009355771.USD","IE00B4R5TH58.HKD","BK4533","LU1057294990.SGD","LU1571399168.USD","IE00BFTCPJ56.SGD","LU1061106388.HKD","BK4599","BK4534","BK4588","LU0058720904.USD","LU0889565916.HKD","LU0868494617.USD","LU2112291526.USD","IE00BJJMRZ35.SGD","LU2242646821.SGD","LU0122379950.USD","IE0002141913.USD","IE00B2B36J28.USD","AMGN","LU2242652126.USD","BK4585","SG9999001440.SGD"],"gpt_icon":0},{"id":"1106155676","title":"安进：贝马替珠单抗（Bema）在Fortitude-101 III期临床试验的初步分析中显示出统计学显著的生存获益","url":"https://stock-news.laohu8.com/highlight/detail?id=1106155676","media":"美股速递","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1106155676?lang=zh_cn&edition=full","pubTime":"2025-10-20 06:05","pubTimestamp":1760911511,"startTime":"0","endTime":"0","summary":"安进：贝马替珠单抗（Bema）在Fortitude-101 III期临床试验的初步分析中显示出统计学显著的生存获益。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4588","LU0058720904.USD","IE0002141913.USD","IE0009355771.USD","IE00B2B36J28.USD","SG9999001440.SGD","LU0109394709.USD","LU0122379950.USD","LU1023059063.AUD","LU0868494617.USD","BK4566","LU0289739699.SGD","BK4533","IE00BJT1NW94.SGD","BK4581","LU0889565916.HKD","LU2089984988.USD","AMGN","LU2242652126.USD","BK4139","LU1571399168.USD","LU1983299246.USD","LU2468319806.SGD","BK4599","IE00B4R5TH58.HKD","LU1057294990.SGD","LU2242646821.SGD","LU2112291526.USD","BK4585","LU1061106388.HKD","LU0320765992.SGD","IE00BJJMRZ35.SGD","BK4534","IE00BFTCPJ56.SGD"],"gpt_icon":0},{"id":"2576825878","title":"ESMO大会本周重磅开幕；超 4款国产新药出海，翰森、奥赛康、维立志博科伦 ADC新药获批上市 Insight新药周报","url":"https://stock-news.laohu8.com/highlight/detail?id=2576825878","media":"动脉网","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2576825878?lang=zh_cn&edition=full","pubTime":"2025-10-19 20:05","pubTimestamp":1760875500,"startTime":"0","endTime":"0","summary":"ESMO大会本周开幕，据Insight数据库统计，10月12日至18日，全球86款创新药研发有新进展，其中1款获批上市，5款申报上市，2款首次启动III期临床，19款启动临床，26款申报临床。境外部分，本周23款药物研发有推进，包括1款首次启动III期临床，9款首次启动临床，8款首次获批临床。此外，诺华公布了伊普可泮Ⅲ期最终分析结果。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025102001380797372ce2&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["AMGN","LU2242652126.USD","INAQU","BK4533","BK4599","IE0002141913.USD","IE00B4R5TH58.HKD","BK4566","IE00BJT1NW94.SGD","BK4534","LU0122379950.USD","LU0889565916.HKD","LU0868494617.USD","BK4581","BK4231","LU2242646821.SGD","LU1983299246.USD","LU2468319806.SGD","LU2089984988.USD","LU0320765992.SGD","BK4585","LU1571399168.USD","IE00B2B36J28.USD","IE00BJJMRZ35.SGD","IE0009355771.USD","BK4139","BK4080","LU1061106388.HKD","LU1057294990.SGD","LU0289739699.SGD","ADC","LU0109394709.USD","LU1023059063.AUD","SG9999001440.SGD","BK4588","LU0058720904.USD","LU2112291526.USD","IE00BFTCPJ56.SGD"],"gpt_icon":0},{"id":"2576570703","title":"安进涨0.90% 股价突破300美元大关","url":"https://stock-news.laohu8.com/highlight/detail?id=2576570703","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2576570703?lang=zh_cn&edition=full","pubTime":"2025-10-16 21:57","pubTimestamp":1760623026,"startTime":"0","endTime":"0","summary":"北京时间2025年10月16日21时57分，安进股票出现异动，股价急速拉升0.90%。截至发稿，该股报300.00美元/股，成交量11.2623万股，换手率0.02%，振幅0.81%。安进股票所在的制药行业中，整体涨幅为0.63%。安进于 2006 年推出了首款癌症治疗药物 Vectibix，并销售骨强化药物 Prolia/Xgeva和 Evenity。公司2023年收购Horizon带来了多种罕见疾病药物，包括甲状腺眼病药物Tepezza。同时，安进还拥有不断增长的生物仿制药产品组合。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251016215706a6bd2908&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LU2468319806.SGD","IE00BJT1NW94.SGD","LU1571399168.USD","LU1057294990.SGD","BK4581","LU1983299246.USD","LU2242652126.USD","LU2089984988.USD","LU0122379950.USD","SG9999001440.SGD","LU0320765992.SGD","LU1061106388.HKD","IE0002141913.USD","LU2112291526.USD","BK4533","BK4534","BK4599","LU0889565916.HKD","IE00BJJMRZ35.SGD","BK4585","LU0868494617.USD","AMGN","LU0058720904.USD","BK4588","BK4139","LU0289739699.SGD","IE0009355771.USD","LU1023059063.AUD","IE00B2B36J28.USD","LU0109394709.USD","IE00BFTCPJ56.SGD","LU2242646821.SGD","IE00B4R5TH58.HKD","BK4566"],"gpt_icon":0},{"id":"2573883958","title":"安进胆固醇药物在美国降价60%","url":"https://stock-news.laohu8.com/highlight/detail?id=2573883958","media":"格隆汇","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2573883958?lang=zh_cn&edition=full","pubTime":"2025-10-07 15:48","pubTimestamp":1759823333,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.gelonghui.com/rss/live/live.xml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_gelonghui","symbols":["IE00B2B36J28.USD","LU1023059063.AUD","BK4534","LU2468319806.SGD","LU2242652126.USD","AMGN","LU0058720904.USD","BK4599","IE00BJJMRZ35.SGD","BK4566","LU0289739699.SGD","LU1057294990.SGD","LU1983299246.USD","IE00BJT1NW94.SGD","LU2112291526.USD","LU0868494617.USD","BK4533","LU0889565916.HKD","BK4585","IE0002141913.USD","LU2242646821.SGD","BK4139","IE00B4R5TH58.HKD","LU1061106388.HKD","LU0122379950.USD","BK4581","LU1571399168.USD","SG9999001440.SGD","LU2089984988.USD","IE00BFTCPJ56.SGD","IE0009355771.USD","LU0109394709.USD","LU0320765992.SGD","BK4588"],"gpt_icon":0},{"id":"2573608427","title":"GoodRx Expands Affordable Access to Cholesterol Drug Repatha","url":"https://stock-news.laohu8.com/highlight/detail?id=2573608427","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2573608427?lang=zh_cn&edition=full","pubTime":"2025-10-06 21:56","pubTimestamp":1759758993,"startTime":"0","endTime":"0","summary":"GoodRx  said Monday it is expanding the availability of Amgen's  cholesterol drug Repatha at a lower price.Starting Monday, patients will be able to use GoodRx to buy Repatha for $239 at over 70,000 pharmacies in the US, GoodRx said, adding that the price represents a savings of about 60% off the retail pharmacy list price.GoodRx shares were up 3.5% in early trading, while Amgen was down 0.5%.Price: 4.69, Change: +0.16, Percent Change: +3.53","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"GoodRx扩大了胆固醇药物Repatha的可负担性","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["IE00BFTCPJ56.SGD","LU0058720904.USD","LU2468319806.SGD","IE00B2B36J28.USD","BK4566","IE00BJT1NW94.SGD","LU0889565916.HKD","BK4534","LU0320765992.SGD","IE00BJJMRZ35.SGD","LU1023059063.AUD","IE00B4R5TH58.HKD","LU0868494617.USD","IE0009355771.USD","BK4581","LU2242652126.USD","AMGN","LU2242646821.SGD","IE0002141913.USD","BK4588","BK4599","LU1057294990.SGD","LU1061106388.HKD","LU2112291526.USD","LU0289739699.SGD","LU1983299246.USD","BK4585","SG9999001440.SGD","LU0122379950.USD","LU2089984988.USD","BK4533","BK4139","GDRX","LU0109394709.USD","LU1571399168.USD","BK4167"],"gpt_icon":0},{"id":"2573608923","title":"Amgen Introduces Direct-to-Patient Access for Repatha in US","url":"https://stock-news.laohu8.com/highlight/detail?id=2573608923","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2573608923?lang=zh_cn&edition=full","pubTime":"2025-10-06 21:46","pubTimestamp":1759758415,"startTime":"0","endTime":"0","summary":"Amgen  said Monday it launched AmgenNow, a direct-to-patient program in the US starting with its cholesterol drug Repatha, or evolucumab.The company said eligible patients can buy Repatha through the program for $239 per month, about 60% lower than the drug's current list price. The program is open to patients who are uninsured, in high-deductible health plans, or prefer to pay out of pocket, according to Amgen.The program will be available to all Repatha patients, including those on Medicare and Medicaid, and will not require step therapy or prior authorization, the company said.Price: 297.00, Change: -0.89, Percent Change: -0.30","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"安进在美国推出Repatha直接面向患者的服务","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["IE00BJJMRZ35.SGD","BK4581","BK4566","LU0320765992.SGD","LU2112291526.USD","IE00BFTCPJ56.SGD","LU0122379950.USD","IE0002141913.USD","LU2242646821.SGD","LU1983299246.USD","BK4588","BK4139","LU0058720904.USD","IE0009355771.USD","IE00B2B36J28.USD","LU2468319806.SGD","BK4534","LU1571399168.USD","BK4585","LU0868494617.USD","LU0109394709.USD","LU1023059063.AUD","IE00B4R5TH58.HKD","BK4533","LU1057294990.SGD","LU0289739699.SGD","IE00BJT1NW94.SGD","LU1061106388.HKD","LU0889565916.HKD","SG9999001440.SGD","AMGN","LU2089984988.USD","BK4599","LU2242652126.USD"],"gpt_icon":0},{"id":"1181136672","title":"安进：患者援助项目面向全体患者开放，涵盖无保险、高免赔额计划及现金支付患者","url":"https://stock-news.laohu8.com/highlight/detail?id=1181136672","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1181136672?lang=zh_cn&edition=full","pubTime":"2025-10-06 21:01","pubTimestamp":1759755687,"startTime":"0","endTime":"0","summary":"安进(Amgen)宣布，其患者援助项目向所有患者群体开放，覆盖范围包括无医疗保险患者、参与高免赔额健康保险计划的患者，以及选择现金或自费支付的患者。该项目旨在为更广泛的患者群体提供药物可及性支持。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0109394709.USD","BK4581","IE0009355771.USD","AMGN","LU0058720904.USD","LU0320765992.SGD","IE00B2B36J28.USD","IE00BJT1NW94.SGD","BK4534","LU2242652126.USD","LU2242646821.SGD","LU1061106388.HKD","BK4139","BK4566","LU0889565916.HKD","BK4533","LU2112291526.USD","LU1023059063.AUD","LU1571399168.USD","LU0289739699.SGD","SG9999001440.SGD","BK4585","LU0868494617.USD","BK4588","IE00BFTCPJ56.SGD","IE00B4R5TH58.HKD","LU1057294990.SGD","LU2468319806.SGD","BK4599","IE0002141913.USD","LU0122379950.USD","IE00BJJMRZ35.SGD","LU1983299246.USD","LU2089984988.USD"],"gpt_icon":0},{"id":"1121063765","title":"里程碑式3期临床试验Vesalius-Cv在涉及12,000名患者的心血管初级预防研究中达到主要终点","url":"https://stock-news.laohu8.com/highlight/detail?id=1121063765","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1121063765?lang=zh_cn&edition=full","pubTime":"2025-10-02 21:02","pubTimestamp":1759410154,"startTime":"0","endTime":"0","summary":"里程碑式3期临床试验Vesalius-Cv在涉及12,000名患者的心血管初级预防研究中成功达到主要终点。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1983299246.USD","IE00BJT1NW94.SGD","BK4534","IE00BJJMRZ35.SGD","LU2468319806.SGD","LU0320765992.SGD","BK4585","LU1023059063.AUD","LU2242652126.USD","BK4139","IE00B4R5TH58.HKD","SG9999001440.SGD","BK4588","AMGN","LU0058720904.USD","LU2242646821.SGD","IE00BFTCPJ56.SGD","BK4581","LU1061106388.HKD","LU1057294990.SGD","LU0868494617.USD","LU2089984988.USD","IE0009355771.USD","LU0122379950.USD","BK4599","LU2112291526.USD","IE0002141913.USD","IE00B2B36J28.USD","BK4566","LU0109394709.USD","LU0889565916.HKD","LU0289739699.SGD","BK4533","LU1571399168.USD"],"gpt_icon":0},{"id":"2572588989","title":"Biocon Biologics, Amgen Settle Patent Dispute, Clearing US Launch of Denosumab Biosimilars","url":"https://stock-news.laohu8.com/highlight/detail?id=2572588989","media":"MT Newswires Live","labels":["corporation"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2572588989?lang=zh_cn&edition=full","pubTime":"2025-10-01 13:14","pubTimestamp":1759295668,"startTime":"0","endTime":"0","summary":"Biocon (NSE:BIOCON, BOM:532523) subsidiary, Biocon Biologics, has settled patent litigation with Amgen in the U.S. District Court of New Jersey, enabling the launch of its denosumab biosimilars, Bosay","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"Biocon Biologics与安进解决专利纠纷，批准Denosumab生物仿制药在美国上市","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK4581","LU0889565916.HKD","LU1571399168.USD","SG9999001440.SGD","AMGN","IE00BJJMRZ35.SGD","LU0122379950.USD","IE0002141913.USD","BK4534","BK4588","LU0868494617.USD","IE00BJT1NW94.SGD","LU0058720904.USD","LU0289739699.SGD","BK4585","LU2089984988.USD","BK4599","IE00B4R5TH58.HKD","LU0109394709.USD","LU2468319806.SGD","BK4533","IE00BFTCPJ56.SGD","IE00B2B36J28.USD","LU0320765992.SGD","BK4566","LU2112291526.USD","LU1061106388.HKD","LU2242652126.USD","LU1983299246.USD","BK4139","LU1057294990.SGD","IE0009355771.USD","LU2242646821.SGD","LU1023059063.AUD"],"gpt_icon":0},{"id":"2572371902","title":"安进盘中异动 急速拉升3.04%","url":"https://stock-news.laohu8.com/highlight/detail?id=2572371902","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2572371902?lang=zh_cn&edition=full","pubTime":"2025-10-01 00:40","pubTimestamp":1759250426,"startTime":"0","endTime":"0","summary":"北京时间2025年10月01日00时40分，安进股票出现异动，股价急速上涨3.04%。截至发稿，该股报282.29美元/股，成交量140.401万股，换手率0.26%，振幅2.93%。机构评级方面，在所有33家参与评级的机构中，42%的券商给予买入建议，48%的券商给予持有建议，10%的券商给予卖出建议。安进股票所在的制药行业中，整体涨幅为2.06%。安进于 2006 年推出了首款癌症治疗药物 Vectibix，并销售骨强化药物 Prolia/Xgeva和 Evenity。同时，安进还拥有不断增长的生物仿制药产品组合。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251001004026a44eec80&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LU2468319806.SGD","IE00BJT1NW94.SGD","LU1571399168.USD","LU1057294990.SGD","BK4581","LU1983299246.USD","LU2242652126.USD","LU2089984988.USD","LU0122379950.USD","SG9999001440.SGD","LU0320765992.SGD","LU1061106388.HKD","IE0002141913.USD","LU2112291526.USD","BK4533","BK4534","BK4599","LU0889565916.HKD","IE00BJJMRZ35.SGD","BK4585","LU0868494617.USD","AMGN","LU0058720904.USD","BK4588","BK4139","LU0289739699.SGD","IE0009355771.USD","LU1023059063.AUD","IE00B2B36J28.USD","LU0109394709.USD","IE00BFTCPJ56.SGD","LU2242646821.SGD","IE00B4R5TH58.HKD","BK4566"],"gpt_icon":0},{"id":"2570833168","title":"US Equity Indexes Rise in Midday Trading","url":"https://stock-news.laohu8.com/highlight/detail?id=2570833168","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2570833168?lang=zh_cn&edition=full","pubTime":"2025-09-27 00:32","pubTimestamp":1758904365,"startTime":"0","endTime":"0","summary":"US benchmark stock indexes rose in midday trading Friday as investors assessed the latest inflation data.The S&P 500 added 0.4% to 6,632.5, the Dow Jones Industrial Average gained 0.6% to 46,240.5, wh","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"美国股指午盘上涨","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["GOOGL","AMGN","GOOG","MNQmain","LU1934455277.USD","DOG","QID","DDM","BK4538","UDOW","BK4543","USJW.SI","NQmain","LU0130102774.USD","BK4602","QLD","LU2237443622.USD","LU1244550494.USD",".IXIC","NVIW.SI","IE00B775H168.HKD","LU2098885051.SGD","IE00BZ1G4Q59.USD","LU1629891620.HKD","PSQ","IE00BWXC8680.SGD","LU0203201768.USD","SQQQ","TSYW.SI","DXD",".SPX","DJX",".DJI","LU1057294990.SGD","LU2168563687.JPY","LU2471134952.CNY","LU0149725797.USD","LU0203347892.USD","LU0289941410.SGD","IE00B19Z8W00.USD","USAW.SI","TQQQ","LU1280957306.USD","LU1633808545.USD","MYMmain","SDOW","LU2065169927.USD","LU0820561909.HKD","EQR"],"gpt_icon":1},{"id":"2570399889","title":"Amgen to Invest $650 Million in Expanding US Manufacturing Network","url":"https://stock-news.laohu8.com/highlight/detail?id=2570399889","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2570399889?lang=zh_cn&edition=full","pubTime":"2025-09-26 21:08","pubTimestamp":1758892088,"startTime":"0","endTime":"0","summary":"Amgen to Invest $650 Million in Expanding US Manufacturing Network","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"安进将投资6.5亿美元扩大美国制造网络","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK4588","LU2112291526.USD","SG9999001440.SGD","LU2242646821.SGD","LU2089984988.USD","LU1061106388.HKD","LU1983299246.USD","BK4533","BK4534","BK4599","IE0009355771.USD","LU0889565916.HKD","BK4585","IE00BJT1NW94.SGD","LU2468319806.SGD","IE00B2B36J28.USD","BK4581","AMGN","LU0109394709.USD","LU0122379950.USD","IE00B4R5TH58.HKD","IE00BJJMRZ35.SGD","BK4566","IE00BFTCPJ56.SGD","LU1023059063.AUD","LU0058720904.USD","LU0868494617.USD","LU1057294990.SGD","LU0320765992.SGD","LU2242652126.USD","BK4139","LU0289739699.SGD","LU1571399168.USD","IE0002141913.USD"],"gpt_icon":0},{"id":"2570059835","title":"花旗上调安进目标价至315美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2570059835","media":"格隆汇","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2570059835?lang=zh_cn&edition=full","pubTime":"2025-09-25 11:05","pubTimestamp":1758769541,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.gelonghui.com/rss/live/live.xml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_gelonghui","symbols":["LU2112291526.USD","LU1162221912.USD","LU2456880835.USD","IE00B2B36J28.USD","BK4581","LU0320765646.SGD","LU0130102774.USD","LU0109394709.USD","IE00BFTCPJ56.SGD","LU2089984988.USD","BK4533","BK4599","LU2125154935.USD","LU1791807156.HKD","IE0009355771.USD","LU0648001328.SGD","LU1668664300.SGD","LU1983299246.USD","BK4534","LU1267930227.SGD","AMGN","LU0052756011.USD","LU0072461881.USD","SG9999001440.SGD","LU1061106388.HKD","BK4504","LU2125154778.USD","LU0130517989.USD","LU0289739699.SGD","LU0128525689.USD","LU1244550221.USD","LU0106831901.USD","LU0320765992.SGD","IE00BJT1NW94.SGD","IE00BJJMRZ35.SGD","LU1244550494.USD","LU2242646821.SGD","BK4566","LU0889565916.HKD","LU1057294990.SGD","LU2242652126.USD","LU1571399168.USD","BK4207","BK4559","LU0122379950.USD","BK4585","IE00B4R5TH58.HKD","LU1201861249.SGD","IE0002141913.USD","LU0170899867.USD"],"gpt_icon":0},{"id":"2569770535","title":"Citigroup Adjusts Price Target on Amgen to $315 From $310, Maintains Neutral Rating","url":"https://stock-news.laohu8.com/highlight/detail?id=2569770535","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2569770535?lang=zh_cn&edition=full","pubTime":"2025-09-24 18:13","pubTimestamp":1758708793,"startTime":"0","endTime":"0","summary":"Amgen (AMGN) has an average rating of overweight and mean price target of $310.92, according to analysts polled by FactSet.(MT Newswires covers equity, commodity and economic research from major banks","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"花旗将安进目标价从310美元调整至315美元，维持中性评级","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["AMGN"],"gpt_icon":0},{"id":"2568269228","title":"安进公司上涨2.3%，成为涨幅最大的道指成份股","url":"https://stock-news.laohu8.com/highlight/detail?id=2568269228","media":"环球市场播报","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2568269228?lang=zh_cn&edition=full","pubTime":"2025-09-19 22:12","pubTimestamp":1758291120,"startTime":"0","endTime":"0","summary":"美股周五早盘，生物科技巨头安进公司（NASDAQ：AMGN）上涨2.3%，成为涨幅最大的道指成份股。\n\n\n海量资讯、精准解读，尽在新浪财经APP\n\n责任编辑：张俊 SF065","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/usstock/c/2025-09-19/doc-infqzzec7696694.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["SG9999001440.SGD","UDOW","BK4585","LU0289739699.SGD","LU2089984988.USD","IE00BJJMRZ35.SGD","LU2242652126.USD","LU1983299246.USD","LU1061106388.HKD","MYMmain","BK4139","DJX","BK4588","YMmain","LU2242646821.SGD","LU0320765992.SGD","SDOW","LU0889565916.HKD","BK4534","AMGN","BK4581","BK4599","IE0009355771.USD","IE00B2B36J28.USD","LU0058720904.USD","LU2468319806.SGD",".DJI","LU0868494617.USD","BK4533","LU0122379950.USD","DXD","LU0109394709.USD","BK4566","IE0002141913.USD","IE00B4R5TH58.HKD","DOG","LU1571399168.USD","LU2112291526.USD","IE00BFTCPJ56.SGD","LU1057294990.SGD","LU1023059063.AUD","DDM","IE00BJT1NW94.SGD"],"gpt_icon":0},{"id":"2568660282","title":"Amgen's Uplizna Receives European Human Medicines Committee Recommendation for IgG4-Related Disease","url":"https://stock-news.laohu8.com/highlight/detail?id=2568660282","media":"MT Newswires Live","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2568660282?lang=zh_cn&edition=full","pubTime":"2025-09-19 21:54","pubTimestamp":1758290088,"startTime":"0","endTime":"0","summary":"Amgen's  Uplizna has received a positive opinion from the European Medicines Agency's  human medicines committee recommending its approval for adults with active immunoglobulin G4-related disease, a rare autoimmune disorder with no authorized treatments in the EU.The recommendation was based on a phase 3 study of 135 patients that showed Uplizna significantly reduced disease flares compared with placebo, the EMA said Friday.At 52 weeks, 58.8% of patients on Uplizna achieved corticosteroid-free remission without flares versus 22.4% of those on placebo, according to the statement.The regulator said safety findings were consistent with its use in neuromyelitis optica spectrum disorders, for which Uplizna is already approved. The most common side effects included infections, joint and back pain, and low lymphocyte counts, it added.The EMA said the committee's opinion will be forwarded to the European Commission, which will decide on an EU-wide extension of the indication, while national pr","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"安进的Uplizna获得欧洲人类药物委员会针对IgG4相关疾病的推荐","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["EMA","LU2112291526.USD","LU2468319806.SGD","IE00B2B36J28.USD","BK4581","LU0109394709.USD","IE00BFTCPJ56.SGD","LU2089984988.USD","BK4533","BK4599","MDCO","IE0009355771.USD","LU1983299246.USD","BK4534","AMGN","SG9999001440.SGD","LU1061106388.HKD","BK4139","LU0868494617.USD","LU0289739699.SGD","LU0320765992.SGD","IE00BJT1NW94.SGD","IE00BJJMRZ35.SGD","LU2242646821.SGD","LU2242652126.USD","BK4566","LU0889565916.HKD","BK4081","LU1057294990.SGD","LU1571399168.USD","LU1023059063.AUD","BK4588","LU0058720904.USD","LU0122379950.USD","BK4585","IE00B4R5TH58.HKD","IE0002141913.USD"],"gpt_icon":0},{"id":"2568853252","title":"Organon, Shanghai Henlius Say EU Approves Denosumab Biosimilars","url":"https://stock-news.laohu8.com/highlight/detail?id=2568853252","media":"MT Newswires Live","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2568853252?lang=zh_cn&edition=full","pubTime":"2025-09-19 18:34","pubTimestamp":1758278072,"startTime":"0","endTime":"0","summary":"Organon  and partner Shanghai Henlius Biotech said Friday the European Commission granted marketing authorization for the Bildyos and Bilprevda injections, denosumab biosimilars to Prolia and Xgeva.The approvals cover all indications of the reference products, including treatment of osteoporosis and prevention of skeletal-related events in certain cancer patients, the companies said.Under a 2022 agreement, Organon holds exclusive rights to commercialize Bildyos and Bilprevda outside China.Prolia and Xgeva are trademarks registered in Europe by Amgen .","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"Organon、上海复宏汉霖表示欧盟批准Denosumab生物仿制药","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK4599","LU2065171402.SGD","BK4533","IE00B4R5TH58.HKD","LU0320765992.SGD","LU2065171311.SGD","BK4534","BK4585","LU2242646821.SGD","BK1161","LU0889565916.HKD","SG9999001440.SGD","LU2112291526.USD","BK4566","BK4156","LU2065170008.USD","LU1023059063.AUD","LU2242652126.USD","IE0002141913.USD","LU2089984988.USD","IE00BFTCPJ56.SGD","AMGN","IE00B2B36J28.USD","LU1983299246.USD","IE00BJT1NW94.SGD","LU1057294990.SGD","BK4588","IE0009355771.USD","LU0868494617.USD","LU1571399168.USD","LU0289739699.SGD","LU0109394709.USD","BK4581","BK4139","LU2468319806.SGD","LU0122379950.USD","BK4559","BK4007","LU0058720904.USD","OGN","LU1061106388.HKD","02696","LU2065169927.USD","IE00BJJMRZ35.SGD"],"gpt_icon":0},{"id":"1154411420","title":"欧洲药品管理局人用药物委员会建议扩大Uplizna(inebilizumab)治疗适应症，将活动性IgG4相关疾病成人患者纳入治疗范围","url":"https://stock-news.laohu8.com/highlight/detail?id=1154411420","media":"美股速递","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1154411420?lang=zh_cn&edition=full","pubTime":"2025-09-19 18:17","pubTimestamp":1758277039,"startTime":"0","endTime":"0","summary":"欧洲药品管理局人用药物委员会建议扩大Uplizna(inebilizumab)的治疗适应症，将活动性IgG4相关疾病成人患者纳入治疗范围。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE00B2B36J28.USD","LU1023059063.AUD","BK4534","LU2468319806.SGD","LU2242652126.USD","AMGN","LU0058720904.USD","BK4599","IE00BJJMRZ35.SGD","BK4566","LU0289739699.SGD","LU1057294990.SGD","LU1983299246.USD","IE00BJT1NW94.SGD","LU2112291526.USD","LU0868494617.USD","BK4533","LU0889565916.HKD","BK4585","IE0002141913.USD","LU2242646821.SGD","BK4139","IE00B4R5TH58.HKD","LU1061106388.HKD","LU0122379950.USD","BK4581","LU1571399168.USD","SG9999001440.SGD","LU2089984988.USD","IE00BFTCPJ56.SGD","IE0009355771.USD","LU0109394709.USD","LU0320765992.SGD","BK4588"],"gpt_icon":0},{"id":"2568405116","title":"Alnylam Joins Alliance for Genomic Discovery","url":"https://stock-news.laohu8.com/highlight/detail?id=2568405116","media":"MT Newswires Live","labels":["corporation"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2568405116?lang=zh_cn&edition=full","pubTime":"2025-09-18 22:33","pubTimestamp":1758205994,"startTime":"0","endTime":"0","summary":"Illumina  and Nashville Biosciences said Thursday that Alnylam Pharmaceuticals  has joined the Alliance for Genomic Discovery.Alnylam will use the alliance's genomic database to boost drug target discovery, the companies said.Alnylam is the ninth member of the alliance joining AbbVie , Amgen , AstraZeneca , Bayer, Bristol Myers Squibb , GSK , Merck , and Novo Nordisk , the companies said.Price: 103.16, Change: +2.29, Percent Change: +2.27","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"Alnylam加入基因组发现联盟","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK4599","IE000M9KFDE8.USD","LU1670710588.SGD","LU0943347566.SGD","LU0170899867.USD","LU1929549753.HKD","LU0965509283.SGD","LU0320765992.SGD","LU1732800096.USD","LU0985481810.HKD","ABBV","NVO.AU","BMY","BK4566","GSK.UK","BK4550","LU0061475181.USD","ILMN","LU0096364046.USD","SG9999013999.USD","IE00BFTCPJ56.SGD","ALNY","AMGN","LU0310799852.SGD","LU0553294199.USD","IE0004445239.USD","LU1066053197.SGD","SG9999014575.USD","MRK","IE0002270589.USD","BK4588","AZN","IE00BVYPNV92.GBP","SG9999015341.SGD","LU0310800379.SGD","LU1267930573.SGD","LU0114720955.EUR","SG9999015358.SGD","LU1267930490.SGD","LU1989772923.USD","LU0266013472.USD","LU1037948541.HKD","LU2360032135.SGD","LU1162221912.USD","LU0417517546.SGD","GSK","SG9999011175.SGD","IE00B1BXHZ80.USD","IE00BJJMRZ35.SGD"],"gpt_icon":1}],"profile":{"websiteUrl":"http://www.amgen.com","stockEarnings":[{"period":"1week","weight":-0.0236},{"period":"1month","weight":0.0449},{"period":"3month","weight":-0.0483},{"period":"6month","weight":0.0389},{"period":"1year","weight":-0.0758},{"period":"ytd","weight":0.1194}],"compareEarnings":[{"period":"1week","weight":0.0194},{"period":"1month","weight":0.0244},{"period":"3month","weight":0.063},{"period":"6month","weight":0.2299},{"period":"1year","weight":0.1692},{"period":"ytd","weight":0.1556}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"安进公司于1980年在加利福尼亚成立，并于1987年成为特拉华州的一家公司。该公司发现、开发、制造和交付创新药物，以对抗世界上一些最棘手的疾病。该公司专注于高度未满足的医疗需求领域，并利用其专业知识努力寻求能够显著改善人们生活的解决方案，同时还能减轻疾病带来的社会和经济负担。该公司在40多年前帮助启动了生物技术产业，并已成长为世界领先的独立生物技术公司之一。","yearOnYearQuotes":[{"month":1,"riseRate":0.642857,"avgChangeRate":0.034093},{"month":2,"riseRate":0.47619,"avgChangeRate":-0.001155},{"month":3,"riseRate":0.52381,"avgChangeRate":0.019224},{"month":4,"riseRate":0.452381,"avgChangeRate":-0.002852},{"month":5,"riseRate":0.52381,"avgChangeRate":0.024179},{"month":6,"riseRate":0.5,"avgChangeRate":0.003875},{"month":7,"riseRate":0.767442,"avgChangeRate":0.052562},{"month":8,"riseRate":0.604651,"avgChangeRate":0.004451},{"month":9,"riseRate":0.511628,"avgChangeRate":0.002296},{"month":10,"riseRate":0.534884,"avgChangeRate":0.020989},{"month":11,"riseRate":0.619048,"avgChangeRate":0.019128},{"month":12,"riseRate":0.642857,"avgChangeRate":0.047779}],"exchange":"NASDAQ","name":"安进","nameEN":"Amgen"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.35.4","shortVersion":"4.35.4","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"安进(AMGN)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供安进(AMGN)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"安进,AMGN,安进股票,安进股票老虎,安进股票老虎国际,安进行情,安进股票行情,安进股价,安进股市,安进股票价格,安进股票交易,安进股票购买,安进股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"安进(AMGN)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供安进(AMGN)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}